255 related articles for article (PubMed ID: 26220860)
1. Dixon-based fat-free MR-angiography compared to first pass and steady-state high-resolution MR-angiography using a blood pool contrast agent.
Homsi R; Gieseke J; Kukuk GM; Träber F; Willinek WA; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2015 Nov; 33(9):1035-1042. PubMed ID: 26220860
[TBL] [Abstract][Full Text] [Related]
2. 0.125 mm(3) spatial resolution steady-state MR angiography of the thighs with a blood pool contrast agent using the quadrature body coil only at 1.5 Tesla.
Boschewitz JM; Hadizadeh DR; Kukuk GM; Meyer C; Wilhelm K; Koscielny A; Verrel F; Gieseke J; Schild HH; Willinek WA
J Magn Reson Imaging; 2014 Oct; 40(4):996-1001. PubMed ID: 24845363
[TBL] [Abstract][Full Text] [Related]
3. Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA.
Hadizadeh DR; Gieseke J; Lohmaier SH; Wilhelm K; Boschewitz J; Verrel F; Schild HH; Willinek WA
Radiology; 2008 Nov; 249(2):701-11. PubMed ID: 18769017
[TBL] [Abstract][Full Text] [Related]
4. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
[TBL] [Abstract][Full Text] [Related]
5. Whole-body MR angiography in patients with peripheral arterial disease.
Nielsen YJ
Dan Med Bull; 2010 Dec; 57(12):B4231. PubMed ID: 21122468
[TBL] [Abstract][Full Text] [Related]
6. Subtractionless first-pass single contrast medium dose peripheral MR angiography using two-point Dixon fat suppression.
Leiner T; Habets J; Versluis B; Geerts L; Alberts E; Blanken N; Hendrikse J; Vonken EJ; Eggers H
Eur Radiol; 2013 Aug; 23(8):2228-35. PubMed ID: 23591617
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation.
Michaely HJ; Attenberger UI; Dietrich O; Schmitt P; Nael K; Kramer H; Reiser MF; Schoenberg SO; Walz M
Invest Radiol; 2008 Sep; 43(9):635-41. PubMed ID: 18708857
[TBL] [Abstract][Full Text] [Related]
8. MR angiography of infrapopliteal arteries in patients with peripheral arterial occlusive disease by using Gadofosveset at 3.0 T: diagnostic accuracy compared with selective DSA.
Bonel HM; Saar B; Hoppe H; Keo HH; Husmann M; Nikolaou K; Ludwig K; Szucs-Farkas Z; Srivastav S; Kickuth R
Radiology; 2009 Dec; 253(3):879-90. PubMed ID: 19864508
[TBL] [Abstract][Full Text] [Related]
9. Whole-body magnetic resonance angiography with additional steady-state acquisition of the infragenicular arteries in patients with peripheral arterial disease.
Nielsen YW; Eiberg JP; Løgager VB; Just S; Schroeder TV; Thomsen HS
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):484-91. PubMed ID: 19957180
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic performance of contrast-enhanced MR angiography of the aortoiliac arteries with the blood pool agent Vasovist: initial results in comparison to intra-arterial DSA].
Vogt FM; Herborn CU; Parsons EC; Kröger K; Barkhausen J; Goyen M
Rofo; 2007 Apr; 179(4):412-20. PubMed ID: 17385136
[TBL] [Abstract][Full Text] [Related]
11. Equilibrium-phase MR angiography: Comparison of unspecific extracellular and protein-binding gadolinium-based contrast media with respect to image quality.
Erb-Eigner K; Taupitz M; Asbach P
Contrast Media Mol Imaging; 2016; 11(1):71-6. PubMed ID: 26265484
[TBL] [Abstract][Full Text] [Related]
12. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience.
Nikolaou K; Kramer H; Grosse C; Clevert D; Dietrich O; Hartmann M; Chamberlin P; Assmann S; Reiser MF; Schoenberg SO
Radiology; 2006 Dec; 241(3):861-72. PubMed ID: 17032914
[TBL] [Abstract][Full Text] [Related]
13. High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T.
Spuentrup E; Jacobs JE; Kleimann JF; Wiethoff AJ; Poggenborg J; Brinker G; Loehr M; Möller-Hartmann W; Botnar RM; Ernestus RI; Lackner KJ
Rofo; 2010 Dec; 182(12):1097-104. PubMed ID: 20803412
[TBL] [Abstract][Full Text] [Related]
14. First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium.
Naehle CP; Müller A; Willinek WA; Meyer C; Hestermann T; Gieseke J; Schild H; Thomas D
J Magn Reson Imaging; 2009 Oct; 30(4):809-16. PubMed ID: 19787726
[TBL] [Abstract][Full Text] [Related]
15. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
[TBL] [Abstract][Full Text] [Related]
16. Gadofosveset-enhanced thoracic MR venography: a comparative study evaluating steady state imaging versus conventional first-pass time-resolved dynamic imaging.
See TC; Patterson AJ; Hilliard NJ; Soh E; Winterbottom AP; Patterson I; Parker RA; Graves MJ; Lomas DJ
Acta Radiol; 2018 Apr; 59(4):418-424. PubMed ID: 28707958
[TBL] [Abstract][Full Text] [Related]
17. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
Voth M; Haneder S; Huck K; Gutfleisch A; Schönberg SO; Michaely HJ
Invest Radiol; 2009 Sep; 44(9):627-33. PubMed ID: 19652610
[TBL] [Abstract][Full Text] [Related]
18. Congenital heart disease in adults: Quantitative and qualitative evaluation of IR FLASH and IR SSFP MRA techniques using a blood pool contrast agent in the steady state and comparison to first pass MRA.
Febbo JA; Galizia MS; Murphy IG; Popescu A; Bi X; Turin A; Collins J; Markl M; Edelman RR; Carr JC
Eur J Radiol; 2015 Oct; 84(10):1921-9. PubMed ID: 26253499
[TBL] [Abstract][Full Text] [Related]
19. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
[TBL] [Abstract][Full Text] [Related]
20. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study.
Rapp JH; Wolff SD; Quinn SF; Soto JA; Meranze SG; Muluk S; Blebea J; Johnson SP; Rofsky NM; Duerinckx A; Foster GS; Kent KC; Moneta G; Middlebrook MR; Narra VR; Toombs BD; Pollak J; Yucel EK; Shamsi K; Weisskoff RM
Radiology; 2005 Jul; 236(1):71-8. PubMed ID: 15987963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
